🔗 Share this article

An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Commerce on Social Networks

Additionally, a robust market exists on messaging services, where communities with thousands of members share comparison images, injection guides and claims of rapid British shipping. Vendors market the substance there before redirecting customers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and chemists have warned that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.

Several professionals said the popularity for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for human use under the British medical regulations.

Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate medicines, marketing, and customer regulations, risking fines, prosecution or prison.

Service Response and Content Elimination

Based on the social media company, the service has taken down problematic material and prohibited related hashtags and query recommendations. The company said it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Investigations also found groups with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with numerous of users, populated with photos of slimming results, glowing reviews and detailed guides for preparing or administering at home.

After minutes of joining one group, a vendor shared WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Product Details and Pricing

Inside these groups, posts display black plastic parcels with postal service stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how much time a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram stated it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose users to potentially serious medical dangers”.